Company

vTv Therapeutics

As of the edition of 20 October 2026, vTv Therapeutics runs 7 drugs; it is on route A at 2 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Went quiet4
Stopped2
Total7

Where it needs a new molecule

Route A at 2 targets, route B at 0 targets.

Three of its 2 rows, by target and route
TargetRoute
F9 Coagulation factor IXRoute A
AGER Advanced glycation end product-specific receptorRoute A

All 2 rows on route A or B

In the product

2 company-target rows on route A or B; 0 are not shown here, and no score is.

Where its trials are

  • Nutrition and metabolism: 7 trials led
  • Hormones: 6 trials led
  • Mental health: 4 trials led